4354 J. Agric. Food Chem., Vol. 53, No. 11, 2005
Ha and Kubo
(8) Kubo, I.; Kim, M.; Naya, K.; Komatsu, S.; Yamagiwa, Y.;
Ohashi, K.; Sakamoto, Y.; Hirakawa, S.; Kamikawa, T. Pros-
taglandin synthetase inhibitors from the African medicinal plant
Ozoroa mucronata. Chem. Lett. 1987, 6, 1101-1104.
(9) Kubo, I.; Komatsu, S.; Ochi, M. Molluscicides from the cashew
Anacardium occidentale and their large-scale isolation. J. Agric.
Food Chem. 1986, 34, 970-973.
(10) Kubo, I.; Kinst-Hori, I.; Yokokawa, Y. Tyrosinase inhibitors from
Anacardium occidentale fruits. J. Nat. Prod. 1994, 57, 545-
551.
(11) Gibian, M. J.; Galaway, R. A. Steady-state kinetics lipoxygenase
oxygenation of unsaturated fatty acid. Biochemistry 1976, 15,
4209-4214.
(12) Rickert, K. W.; Klinman, J. P. Nature of hydrogen transfer in
soybean lipoxygenase 1: separation of primary and secondary
isotope effects. Biochemistry 1999, 38, 12218-12228.
(13) Ruddat, V. C.; Whitman, S.; Holman, T. R.; Bernasconi, C. F.
Stopped-flow kinetics investigations of the activation of soybean
lipoxygenase-1 and the influence of inhibitors on the allosteric
site. Biochemistry 2003, 42, 4172-4178.
(14) Morrison, J. F.; Walsh, C. T. The behavior and significance of
slow-binding enzyme inhibitors. AdV. Enzymol. 1988, 61, 201-
301.
(15) Copeland, R. A. Enzyme: A practical introduction to structure,
mechanism, and data analysis; Wiley-VCH: New York, 2000;
pp 266-332.
(16) Axelrod, B.; Cheesbrough, T. M.; Laakso, S. Lipoxygenase from
soybeans. Methods Enzymol. 1981, 71, 441-457.
(17) Schilstra, M. J.; Veldink, G. A.; Verhagen, J.; Vliegenthart, J.
F. G. Effect of lipid hydroperoxide on lipoxygenase kinetics.
Biochemistry 1992, 31, 7692-7699.
(18) Berry, H.; Debat, H.; Larreta-Garde, V. Excess substrate inhibi-
tion of soybean lipoxygenase-1 is mainly oxygen-dependent.
FEBS Lett. 1997, 408, 324-326.
activity (7, 10), suggesting that interaction of the double bond
with a specific amino acid residue in the enzymes is unlikely.
Anacardic acids are amphipathic molecules, so that their
hydrophobic properties dominate the properties of the molecule.
The precise explanation still remains unclear, but it seems that
these enzymes commonly possess a relatively nonspecific and
hydrophobic domain. The hydrophobic pentadec(en)yl side chain
in anacardic acids likely interacts with this hydrophobic domain
and disrupts enzymes’ quaternary structure (27), because native
proteins form a sort of intramolecular micelle in which their
nonpolar side chains are largely out of contact with the water-
based test solution. The hydrophilic head part of anacardic acids
first binds with the salicylic acid portion like a “hook” in
attaching itself to the hydrophilic portion of the molecule, and
then the hydrophobic tail portion begins interacting with the
hydrophobic domain. This concept can be more broadly
conceivable because the hydrophobic alkyl side chain should
allow for conformational flexibility and interacts with many
types of the hydrophobic domains in different enzymes. Anac-
ardic acids’ nonspecificity of enzyme inhibition supports this
assumption.
In summary, safety is a primary consideration for antioxidants
in food products, which may be utilized in unregulated quanti-
ties. That anacardic acids are found in many edible plants that
have been consumed for many years should be a considerable
advantage. Metal chelation capacity of anacardic acids is their
additional advantage because it reduces the concentration of the
catalyzing transition metal in lipid peroxidation. It is known
that chelating agents, which form bonds with a metal, are
effective as secondary antioxidants because they reduce the
redox potential, thereby stabilizing the oxidized form of the
metal ion. Despite the adventage of the isolation from regularly
consumed edible plants, biological significance of anacardic acid
as lipoxygenase inhibitors in living systems is still largely
unknown. Thus, it is not clear if ingested anacardic acids are
absorbed into the system through the intestinal tract and
delivered to the places where lipoxygenase inhibitors are needed.
The relevance of the in vitro experiments in simplified systems
to in vivo protection from oxidative damage should be carefully
considered. Their further evaluation is needed from not only
one aspect, but from a whole and dynamic perspective.
(19) Nagabhushana, K. S.; Shobha, S. V.; Ravindranath, B. Selective
ionophoric properties of anacardic acid. J. Nat. Prod. 1995, 58,
807-810.
(20) Kubo, J.; Lee, J. R.; Kubo, I. Anti-Helicobacter pylori agents
from the cashew apple. J. Agric. Food Chem. 1999, 47, 533-
537.
(21) Irie, J.; Murata, M.; Homma, S. Glycerol-3-phosphate dehydro-
genase inhibitors, anacardic acids, from Ginkgo biloba. Biosci.
Biotechnol. Biochem. 1996, 60, 240-243.
(22) Coates, N. J.; Gilpin, M. L.; Gwynn, M. N.; Lewis, D. E.; Milner,
P. H.; Spear, S. R.; Tyler, J. W. SB-202742, a novel â-lactamase
inhibitor isolated from Spondias mombin. J. Nat. Prod. 1994,
57, 654-657.
(23) Hird, N. W.; Milner, P. H. Synthesis and â-lactamase inhibition
of anacardic acids and their analogues. Bioorg. Med. Chem. Lett.
1994, 4, 1423-1428.
LITERATURE CITED
(24) Toyomizu, M.; Sugiyama, S.; Jin, R. L.; Nakatsu, T. R-Glu-
cosidase and aldose reductase inhibitors: constituents of cashew,
Anacardium occidentale, nut shell liquids. Phytother. Res. 1993,
7, 252-254.
(25) Grazzini, R.; Hesk, D.; Heininger, E.; Hildenbrandt, G.; Reddy,
C. C.; Cox-Foster, D.; Medford, J.; Craig, R.; Mumma, R. O.
Inhibition of lipoxygenase and prostaglandin endoperoxide
synthase by anacardic acids. Biochem. Biophys. Res. Commun.
1991, 176, 775-780.
(26) Bhattacharya, S. K.; Mukhopadhyay, M.; Rao, Patchala, J. R.
M.; Bagchi, A.; Ray, A. B. Pharmacological investigation on
sodium salt and acetyl derivative of anacardic acid. Phytother.
Res. 1987, 1, 127-131.
(27) Hasinoff, B. B.; Davey, J. P. The inhibition of a membrane-
bound enzyme as a model for anaesthetic action and drug
toxicity. Biochem. J. 1989, 258, 101-107.
(1) Gardner, H. W. Biological roles and biochemistry of the
lipoxygenase pathway. HortScience 1995, 30, 197-205.
(2) Gardner, H. W. Recent investigations into the lipoxygenase
pathway of plants. Biochim. Biophys. Acta 1991, 1084, 221-
239.
(3) Cornicelli, J. A.; Trivedi, B. K. 15-Lipoxygenase and its
inhibition: a novel therapeutic target for vascular disease. Curr.
Pharm. Des. 1999, 5, 11-20.
(4) Kris-Etherton, P. M.; Keen, C. L. Evidence that the antioxidant
flavonoids in tea and cocoa are beneficial for cardiovascular
health. Curr. Opin. Lipidol. 2002, 13, 41-49.
(5) Grechkin, A. Recent developments in biochemistry of the plant
lipoxygenase pathway. Prog. Lipid Res. 1998, 37, 317-352.
(6) Richard-Forget, F.; Gauillard, F.; Hugues, M.; Jean-Marc, T.;
Boivin, P.; Nicolas, J. Inhibition of horse bean and germinated
barley lipoxygenases by some phenolic compounds. J. Food Sci.
1995, 60, 1325-1329.
Received for review November 1, 2004. Revised manuscript received
February 7, 2005. Accepted March 4, 2005.
(7) Shobha, S. V.; Ramadoss, C. S.; Ravindranath, B. Inhibition of
soybean lipoxygenase-1 by anacardic acids, cardols, and car-
danols. J. Nat. Prod. 1994, 57, 1755-1757.
JF048184E